Literature DB >> 8170989

A cellular factor is required for transcription of vaccinia viral intermediate-stage genes.

R Rosales1, G Sutter, B Moss.   

Abstract

The cytoplasmic location of vaccinia virus replication and evidence that the multisubunit DNA-dependent RNA polymerase, early and late stage transcription factors, capping and methylating enzymes, and poly(A) polymerase are virus encoded raised the possibility that all of the proteins needed for viral mRNA synthesis are of viral origin. Previous studies showed that four components from infected cells, the viral RNA polymerase and capping enzyme and two factors called vaccinia virus intermediate transcription factors (VITFs) 1 and 2, can reconstitute transcription of vaccinia virus intermediate-stage genes in vitro. Here, we demonstrate that VITF-2 can be isolated from the nuclei of uninfected HeLa cells as well as from the cytoplasm of infected cells. The proteins with VITF-2 activity from uninfected and infected cells cochromatographed and cosedimented, suggesting that they are identical. VITF-2 activity was found in extracts of other uninfected human and monkey cells but not in nonpermissive Trichoplusia ni insect cells or in conditionally permissive rabbit kidney 13 cells. VITF-2 activity was present, however, in a permissive line of rabbit kidney 13 cells that had been stably transfected with the vaccinia virus K1L host range gene. We suggest that the VITF-2 level acts as a gauge of the permissive state of the cell and thereby regulates the length of the early prereplicative phase of the infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8170989      PMCID: PMC43668          DOI: 10.1073/pnas.91.9.3794

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  Hybridization and sedimentation studies on "early" and "late" vaccinia messenger RNA.

Authors:  K I Oda; W K Joklik
Journal:  J Mol Biol       Date:  1967-08-14       Impact factor: 5.469

2.  Cell proliferative response to vaccinia virus is mediated by VGF.

Authors:  R M Buller; S Chakrabarti; B Moss; T Fredrickson
Journal:  Virology       Date:  1988-05       Impact factor: 3.616

3.  Localization and sequence of a vaccinia virus gene required for multiplication in human cells.

Authors:  S Gillard; D Spehner; R Drillien; A Kirn
Journal:  Proc Natl Acad Sci U S A       Date:  1986-08       Impact factor: 11.205

4.  Purification and characterization of a transcription termination factor from vaccinia virions.

Authors:  S Shuman; S S Broyles; B Moss
Journal:  J Biol Chem       Date:  1987-09-05       Impact factor: 5.157

5.  I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Science       Date:  1988-10-28       Impact factor: 47.728

6.  Influence of RNA polymerase II upon vaccinia virus-related translation examined by means of alpha-amanitin.

Authors:  S Wilton; S Dales
Journal:  Virus Res       Date:  1986-09       Impact factor: 3.303

7.  Purification of a factor required for transcription of vaccinia virus early genes.

Authors:  S S Broyles; L Yuen; S Shuman; B Moss
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

8.  Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor.

Authors:  P A Baeuerle; D Baltimore
Journal:  Cell       Date:  1988-04-22       Impact factor: 41.582

9.  In vitro binding of cell-specific and ubiquitous nuclear proteins to the octamer motif of the SV40 enhancer and related motifs present in other promoters and enhancers.

Authors:  R Rosales; M Vigneron; M Macchi; I Davidson; J H Xiao; P Chambon
Journal:  EMBO J       Date:  1987-10       Impact factor: 11.598

10.  Derepression of a novel class of vaccinia virus genes upon DNA replication.

Authors:  J C Vos; H G Stunnenberg
Journal:  EMBO J       Date:  1988-11       Impact factor: 11.598

View more
  30 in total

1.  Regulation of viral intermediate gene expression by the vaccinia virus B1 protein kinase.

Authors:  G R Kovacs; N Vasilakis; B Moss
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Vaccinia virion protein VP8, the 25 kDa product of the L4R gene, binds single-stranded DNA and RNA with similar affinity.

Authors:  C D Bayliss; G L Smith
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

3.  The vaccinia virus H5R gene encodes late gene transcription factor 4: purification, cloning, and overexpression.

Authors:  G R Kovacs; B Moss
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

4.  The vaccinia virus A18R DNA helicase is a postreplicative negative transcription elongation factor.

Authors:  Y Xiang; D A Simpson; J Spiegel; A Zhou; R H Silverman; R C Condit
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

5.  A new vaccinia virus intermediate transcription factor.

Authors:  P Sanz; B Moss
Journal:  J Virol       Date:  1998-08       Impact factor: 5.103

6.  Isolation and characterization of a Chinese hamster ovary mutant cell line with altered sensitivity to vaccinia virus killing.

Authors:  C H Bair; C S Chung; I A Vasilevskaya; W Chang
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 7.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

8.  Cascade regulation of vaccinia virus gene expression is modulated by multistage promoters.

Authors:  Zhilong Yang; Liliana Maruri-Avidal; Jerry Sisler; Carey A Stuart; Bernard Moss
Journal:  Virology       Date:  2013-10-03       Impact factor: 3.616

9.  Vaccinia virus gene A18R encodes an essential DNA helicase.

Authors:  D A Simpson; R C Condit
Journal:  J Virol       Date:  1995-10       Impact factor: 5.103

10.  Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.

Authors:  G Sutter; A Ramsey-Ewing; R Rosales; B Moss
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.